Jiuzhang is the first company that identified, used, and developed their patented Chlorogenic acid product as a therapy for cancer, and conducted professional, independently reviewed, clinical trials. In fact, the product has successfully completed two clinical trials including passing all the safely protocols. Additionally, by way of independent verification, MHG has sent samples for sterility and efficacy testing to our partner Lab in Germany, with no issues reported. 

As the global leader in CHA technology, Jiuzhang Biotech has achieved groundbreaking success in extracting and purifying CHA to a remarkable 99.9% purity using proprietary methods. This advancement has paved the way for the development of a wide range of pharmaceutical, health, and skincare products that address some of the most pressing health challenges today.